Enzumide 40 mg contains Enzalutamide, a second-generation androgen receptor inhibitor designed to suppress prostate cancer growth driven by androgens (male hormones). It is widely used in advanced prostate cancer treatment protocols.

🔬 Mechanism of Action

Enzalutamide inhibits androgen receptor signaling by:

• Blocking androgen binding to the receptor
• Preventing nuclear translocation of the receptor
• Inhibiting DNA binding and transcription of androgen-responsive genes

As a result, it reduces tumor growth and slows disease progression in prostate cancer patients.

💊 Indications

Enzumide 40 mg is indicated for:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC)
• Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
• Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

It may be used with ongoing androgen deprivation therapy (ADT) as prescribed by an oncologist.

📌 Key Features

• Strength: 40 mg
• Dosage Form: Oral capsule
• Therapeutic Class: Androgen Receptor Inhibitor
• Typical Regimen: 160 mg daily (4 capsules of 40 mg), taken orally once daily
• Monitoring: Regular PSA levels, blood pressure, and overall clinical evaluation required

⚕️ Benefits

• Potent androgen receptor blockade
• Improves overall survival in advanced prostate cancer
• Delays disease progression and metastasis
• Oral therapy for patient convenience

⚠️ Precautions

• Risk of fatigue, hypertension, and hot flashes
• Rare risk of seizures
• Monitor for cardiovascular complications
• Avoid during pregnancy (not for use in women)
• Use strictly under oncologist supervision

Enzumide 40 mg (Enzalutamide Capsules) provides an advanced hormonal therapy option for prostate cancer management, helping improve survival and delay progression when used under expert medical care.